Previous Close | 37.57 |
Open | 37.57 |
Bid | 28.85 |
Ask | 31.35 |
Strike | 130.00 |
Expire Date | 2024-11-15 |
Day's Range | 37.57 - 37.57 |
Contract Range | N/A |
Volume | |
Open Interest | 3 |
AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP). With the completion of the acquisition, Landos is now part of AbbVie.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.